Insider Cluster (3 insiders) ·Filed Jul 30, 2026

ATRC

AtriCure, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed2mo ago
Insider cluster: 2 insiders, $1.2M total
Actionable Insight • Neutral

The insider sales are negligible in size and follow a strong earnings beat, suggesting profit-taking rather than informed selling. No bearish read-through; monitor for any larger or accelerating insider sales in coming weeks.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled — T+20d
ATRC ▲ +22.71% at T+20d
NEUTRAL call ✓ call won +22.71% · α vs SPY +18.75% · entry $40.15 → $49.27
Next anchor: T+60d in 20d
Latest observation: T+42 +31.14% FF3 residual α
Entry anchored
Jul 29, 03:59 PM ET
via exchange tick
T+1d
-5.95%
call -5.95% · α -6.66%
$37.76
settled 2mo ago
T+5d
-1.64%
call -1.64% · α -5.27%
$39.49
settled 8w ago
T+20d
+22.71%
call +22.71% · α +18.75%
$49.27
settled 5w ago
T+60d
—
call — · α —
—
in 20d

Price Chart

Loading chart...

Executive Summary

Three AtriCure insiders (Director, CSO, CMO) sold a total of $1.42M in open-market shares over two days following a strong Q2 earnings beat. The sales represent only ~0.07% of market cap and are likely routine profit-taking after the stock's post-earnings run, not a bearish signal.

Key Financial Metrics

Direction
selling
Total Value
$1.4M
Insiders
3

Key Facts

  • Director Sven Wehrwein sold 25,000 shares at $37.84 for $946K on 2026-07-28, also exercised derivatives (non-cash).
  • CSO Vinayak Doraiswamy sold 6,000 shares at $38.88 for $233K on 2026-07-28.
  • CMO Justin Noznesky sold 6,182 shares at $38.80 for $240K on 2026-07-29.
  • Total open-market sales: $1.42M, or ~0.07% of ATRC's $2.1B market cap.
  • Sales occurred 5-6 days after a bullish Q2 2026 earnings release (EPS $0.18 vs $0.03 consensus, revenue +12.8% YoY, raised guidance).

Financial Impact

Insider sales of $1.42M are trivial relative to $2.1B market cap; no material financial impact.

Risk Factors

  • If additional insiders begin selling larger positions, sentiment could shift.
  • Post-earnings profit-taking could cap near-term upside if selling pressure continues.

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
81% bullish (16 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-ATRC-1785481452676
10 reports for ATRC
Performance horizon
100% Hit rate 3 of 3 directional calls best @ T+60▲ +89.53%Jun 14, 2026
Filters
Rows
Reports for ATRC — sortable, filterable
TypeNow
Sep 14, 2026
18d ago
Insider Cluster
NEUTRAL ★ 2/10
$55.79 $58.32▲ +4.53%▲ +2.88%$55.14 (−1.17%)
Aug 7, 2026
8w ago
Insider Cluster
NEUTRAL ★ 2/10
$41.39 $44.30▲ +7.03%▲ +6.63%$55.14 (+33.22%)
Jul 30, 2026
9w ago
Insider Cluster
NEUTRAL ★ 2/10
$40.15 $39.49▼ −1.64%▼ −5.27%$55.14 (+37.33%)
Jul 30, 2026
9w ago
Insider Cluster
NEUTRAL ★ 2/10
$40.15 $39.49▼ −1.64%▼ −5.27%$55.14 (+37.33%)
Jul 23, 2026
10w ago
8-K
BULLISH ★ 6/10
$35.04 $40.15▲ +14.58%▲ +14.21%$55.14 (+57.36%)
Jun 14, 2026
15w ago
Institutional Cluster
BULLISH ★ 5/10
$27.98 $28.44▲ +1.64%▲ +3.03%$55.14 (+97.07%)
Jun 11, 2026
16w ago
Institutional Cluster
BEARISH ★ 5/10
$28.41 $27.12▲ +4.54%▲ +4.97%$55.14 (−94.09%)
May 22, 2026
19w ago
Insider Cluster
NEUTRAL ★ 2/10
$28.29 $26.48▼ −6.40%▼ −8.07%$55.14 (+94.91%)
May 5, 2026
21w ago
8-K
MIXED ★ 6/10
$28.01 $26.69▼ −4.71%▼ −5.84%$55.14 (+96.86%)
Apr 6, 2026
25w ago
DEFA14A
NEUTRAL ★ 3/10
$29.19 $28.66▼ −1.82%▼ −5.95%$55.14 (+88.90%)
Showing 10 of 10

US Market Status

Market Closed — Opens Mon (38h 37m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Jul 31, 2026